付款的透明度
We engage ethically with all providers, and do so transparently and in compliance with country laws, regulations and trade association obligations.\r\n"}}" id="text-acae294a73" class="cmp-text">
我们与所有提供者进行道德参与，并按照国家法律，法规和贸易协会的义务进行透明的工作。
我们认为与医疗保健专业人员和医疗保健组织的互动为患者护理带来了价值
AbbVie is committed to collaborating with health care professionals (HCPs), health care organizations (HCOs) and patient organizations to improve patient health across the globe.
\r\n
\r\nOur interactions with HCPs, HCOs and patient organizations are guided by openness and transparency to ensure public trust and confidence. AbbVie supports disclosure of these relationships wherever possible to demonstrate the integrity of our relationships with HCPs, HCOs and patient organizations.\r\n"}}" id="text-e23546b3ea" class="cmp-text">
\r\n
\r\nOur interactions with HCPs, HCOs and patient organizations are guided by openness and transparency to ensure public trust and confidence. AbbVie supports disclosure of these relationships wherever possible to demonstrate the integrity of our relationships with HCPs, HCOs and patient organizations.\r\n"}}" id="text-e23546b3ea" class="cmp-text">
Abbvie致力于与医疗保健专业人员（HCP），医疗保健组织（HCO）和患者组织合作，以改善全球患者健康。
我们与HCP，HCO和患者组织的互动以开放性和透明度为指导，以确保公众信任和信心。Abbvie在可能的情况下支持披露这些关系，以证明我们与HCP，HCO和患者组织的关系的完整性。
美国境内的HCP/HCO披露
开放付款 - 付费阳光法
The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. To learn more, view our FAQs.\r\n
U.S. Centers for Medicare and Medicaid Services (CMS) Open Payments Website
\r\nIf you have questions on the data contained in the reports, please email TransparencyReporting@abbvie.com.
\r\n"}}" id="text-fffd97bb8e" class="cmp-text">《美国阳光法》，也被称为公开付款 - 《医生付款阳光法》，于2010年被作为《平价医疗法》的一部分颁布为联邦法律。该法案要求包括AbbVie在内的医疗保健制造商跟踪与某些医疗保健提供者（HCP）和医疗保健组织（HCO）（HCO）的金融交易，并每年披露这些交易。我们支持该法案及其目标，即为公众提供对医疗保健行业与HCP之间互动的更大知名度，以确保公众的信任和信心。了解更多， 查看我们的常见问题。
如果您对报告中包含的数据有疑问，请发送电子邮件 [电子邮件保护]。
要访问Allergan的付款和提交给CMS的价值转让，请访问：
要访问美国以外的Allergan HCP / HCO披露，请访问：
Abbvie HCP/HCO披露在美国境外
Information exchanged with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and patient organizations leads to newer and better therapies and, most importantly, enhanced care for patients. We believe interactions with healthcare professionals and healthcare organizations are essential to advance patient care, gain insights into unmet medical needs and progress the development of new medicines. Our interactions with HCPs and HCOs are based on trust, transparency and integrity, with a goal of providing the public with greater visibility into these interactions to ensure public trust and confidence. AbbVie engages in a range of activities from clinical research to sponsorships to educational activities to exchange information on how new medicines fit into the patient pathway. By bringing greater transparency to these relationships, AbbVie demonstrates its ongoing commitment to strengthening the basis for future collaboration.\r\n"}}" id="text-dbd768ebde" class="cmp-text">
与医疗保健专业人员（HCP），医疗机构（HCO）和患者组织交换的信息可带来更新，更好的疗法，最重要的是，对患者的护理增强。我们认为，与医疗保健专业人员的互动和医疗组织的互动对于提高患者护理，了解未满足医疗需求并进步新药物至关重要。狗万正网地址我们与HCP和HCO的互动是基于信任，透明度和诚信，其目的是为公众提供对这些互动的知名度，以确保公众的信任和信心。Abbvie从事一系列活动，从临床研究到赞助到教育活动，以交换有关新药物如何适合患者途径的信息。通过对这些关系提高透明度，Abbvie展示了其持续致力于加强未来合作基础的承诺。
欧洲患者组织关系
AbbVie is committed to making a remarkable impact on patients’ lives and their caregivers. We combine advanced science with a deep knowledge of the patient experience and healthcare systems to help people live better, more productive lives. We pursue learning about patient experiences to understand the issues, concerns and priorities of people affected by disease.
\r\n\r\n
\r\n\r\n
Patient organizations are a source of valuable information and support for patients and their caregivers. We foster patient organization relationships based on mutual trust, respect and goals that reflect AbbVie’s transparent and ethical behavioral standards. Through these relationships, AbbVie contributes to informing patients and caregivers about disease states, treatment options and how to improve quality of life. These partnerships facilitate dialogue between interested parties and help create new, cost-effective health care delivery models.
\r\nAnnually, AbbVie publishes a list of its financial support of European Patient Organizations. Our publication of the following report demonstrates our commitment to transparent disclosure of our financial relationships with patient organizations.
\r\nAbbVie’s 2021 European Patient Organization Report, Additional Document
\r\n*Please note that the report includes support values for Belgium, France, Netherlands, Romania, Portugal and Turkey, which are also disclosed as part of their local Transparency legislation.
\r\n"}}" id="text-b0f477a1a9" class="cmp-text">Abbvie致力于对患者的生活及其护理人员产生显着影响。我们将先进的科学与对患者体验和医疗保健系统的深入了解相结合，以帮助人们生活更好，更有生产力。我们追求对患者经历的学习，以了解受疾病影响的人的问题，关注和优先事项。
患者组织是对患者及其护理人员的宝贵信息和支持的来源。我们基于相互信任，尊重和目标来促进患者组织的关系，这些关系反映了Abbvie的透明和道德行为标准。通过这些关系，Abbvie有助于向患者和看护者告知疾病状态，治疗方案以及如何改善生活质量。这些伙伴关系促进了有关方面之间的对话，并帮助创建新的，具有成本效益的医疗保健提供模式。
Abbvie每年发布其对欧洲患者组织的财政支持列表。我们对以下报告的发布表明，我们致力于透明地披露与患者组织的财务关系。
*请注意，该报告包括比利时，法国，荷兰，罗马尼亚，葡萄牙和土耳其的支持价值，这些价值也作为其当地透明立法的一部分披露。
塞尔维亚 - 赞助专业会议
AbbVie has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and health care issues that improve patient care. In the interest of transparency, we are disclosing the following list of professional conferences sponsored by AbbVie.\r\n
Sponsored Professional Conferences 2013
\r\n
\r\nSponsored Professional Conferences 2014
\r\n
\r\nSponsored Professional Conferences 2015
\r\n
\r\nSponsored Professional Conferences 2016
\r\n
\r\nSponsored Professional Conferences 2017
\r\n
\r\nSponsored Professional Conferences 2018
\r\n
\r\nSponsored Professional Conferences 2019
\r\n
\r\nSponsored Professional Conferences 2020
阿布维（Abbvie）长期致力于支持旨在增加对改善患者护理的科学，临床和医疗保健问题的理解。为了透明，我们披露了Abbvie赞助的以下专业会议清单。
赞助专业会议2013
赞助专业会议2014
赞助专业会议2015
赞助专业会议2016
赞助专业会议2017
赞助专业会议2018
赞助专业会议2019
赞助专业会议2020
外部链接
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.\r\n
Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
\r\n"}}" id="text-9f10c6bfcd" class="cmp-text">除非另有说明，否则所有出现在Internet网站上的产品名称均为其子公司或分支机构Abbvie Inc.拥有或许可的商标。没有Abbvie Inc.事先书面授权，除了确定公司的产品或服务外，不得在本网站上使用任何AbbVie商标，商品名称或贸易裙。
版权所有©2023 Abbvie Inc.美国伊利诺伊州北芝加哥市。
